Liquid Biopsy May Predict Breast Cancer Late Recurrence
Elisa Becze BA, ELS, Editor
Voice
Description
Liquid biopsies—blood tests that detect circulating tumor cells—may help healthcare providers predict which women with hormone receptor-positive (HR+) breast cancer are at higher risk of recurrence, according to the results of a study published in JAMA Oncology.